The Discounted Cash Flow (DCF) valuation of Dechra Pharmaceuticals PLC (DPH.L) is (263.85) GBP. With the latest stock price at 3,866.00 GBP, the upside of Dechra Pharmaceuticals PLC based on DCF is -106.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 9.1% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (307.74) - (98.62) | (263.85) |
| Upside | -108.0% - -102.6% | -106.8% |